In a new job - November 21, 2016
Acesion Pharma recruits new CFO
Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), announced that it has recruited Jakob Dynnes Hansen as its Chief Financial Officer to succeed Herik Moltke, who will continue as CFO of Scandinavian Micro Biodevices that was recently acquired by Zoetis. Jakob joins Acesion from Evolva, a Swiss biotech company, where […]
Collaboration - December 23, 2014
Acesion Pharma Gains Investor
Danish biotech company Acesion Pharma, which is actively developing therapeutic treatments for atrial fibrillation (AF), has raised 15.2 million DKK (2.5 million USD) in a new equity investment round. The round includes Boston-based Broadview Ventures as a new investor and current investor Novo Seeds. The company is working on a treatment to prevent the recurrence […]